Trials / Completed
CompletedNCT04533841
Propranolol and Misoprostol Versus Misoprostol Alone for Induction of Labor in Primigravidas
Propranolol and Misoprostol Versus Misoprostol Alone for Induction of Labor In Primigravidas
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Ahmed mohamed fathy ismail · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To compare propranolol and misoprostol versus misoprostol alone for induction of labour in primigravidas
Detailed description
Candidates will be randomized into 2 groups according to a computer generated sequence. Each candidate will be assigned an opaque sealed envelope containing a paper with her group on it. Both the patient and doctor on duty will be blinded to which group the patient was assigned to. \- Study procedure: 1. Written informed consent will be obtained from all participants prior to the study. 2. Full history taking. 3. General examination. Patients will be subjected to the following: * Patients attending labour room for induction of labour will be divided into two groups. * Both groups, women are induced with Tab misoprostol 25μg applied to posterior vaginal fornix under aseptic precaution and every 6 hours for a maximum of 4 doses. * In group 1, after induction is started with misoprostol placement, 30 minutes will pass before administration of oral Propanolol 20mg * In group 2, after induction is started with misoprostol placement, 30 minutes will pass before administration of oral placebo in the form of sugary tablets. * After induction, women will be monitored for fetal and maternal wellbeing and progress of labour.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Misoprostol | Pt will receive misoprostol for labor induction then after 30 minutes will receive ether propranolol or misoprostol |
| DRUG | Placebo | placebo |
| DRUG | Propranolol | Propranolol |
Timeline
- Start date
- 2020-02-01
- Primary completion
- 2020-09-13
- Completion
- 2020-09-15
- First posted
- 2020-09-01
- Last updated
- 2022-08-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04533841. Inclusion in this directory is not an endorsement.